Compounds > bisantrene
Page last updated: 2024-08-23

bisantrene and Liver Neoplasms

bisantrene has been researched along with Liver Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Du, Y; Huang, Y; Jin, Y; Meng, J; Sun, M; Tang, J; Wang, B; Wu, J; Zhang, J; Zhang, Y1
Clark, G; Coltman, CA; Kuhn, J; Myers, JW; Pocelinko, R; Sandbach, JF; Von Hoff, DD1
Coltman, CA; Kuhn, JG; Myers, JW; Pocelinko, R; Rivkin, S; Van Echo, D; Von Hoff, DD1
Brown, TD; Cowan, JD; Fleming, TR; Shildt, RA1
Hersh, M; Kisner, DL; Kuhn, JG; Ludden, TM; Pirtle, TE; von Hoff, DD; Weiss, GR1

Other Studies

5 other study(ies) available for bisantrene and Liver Neoplasms

ArticleYear
RACK1 promotes the proliferation, migration and invasion capacity of mouse hepatocellular carcinoma cell line in vitro probably by PI3K/Rac1 signaling pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2013, Volume: 67, Issue:4

    Topics: Animals; Anthracenes; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromones; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Liver Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Inbred Strains; Morpholines; Neoplasm Invasiveness; Neuropeptides; Phosphatidylinositol 3-Kinases; rac1 GTP-Binding Protein; Receptors for Activated C Kinase; Signal Transduction; Transfection

2013
Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (CL216,942).
    Cancer research, 1981, Volume: 41, Issue:8

    Topics: Adult; Aged; Anthracenes; Antineoplastic Agents; Bone Marrow; Carcinoma, Hepatocellular; Drug Evaluation; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis

1981
Phase II evaluation of bisantrene in patients with renal cell carcinoma.
    Cancer treatment reports, 1982, Volume: 66, Issue:10

    Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Bone Neoplasms; Drug Evaluation; Female; Humans; Leukocyte Count; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged

1982
Phase II trial of bisantrene in hepatocellular carcinoma: a Southwest Oncology Group Study.
    Cancer treatment reports, 1987, Volume: 71, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Anthracenes; Carcinoma, Hepatocellular; Diagnosis-Related Groups; Drug Evaluation; Female; Humans; Leukopenia; Liver Neoplasms; Male; Middle Aged

1987
A phase I and pharmacokinetic comparison of hepatic arterial and peripheral vein infusions of bisantrene for liver cancer.
    Cancer chemotherapy and pharmacology, 1985, Volume: 15, Issue:2

    Topics: Aged; Anthracenes; Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Drug Evaluation; Half-Life; Hepatic Artery; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Kinetics; Liver Neoplasms; Middle Aged; Regional Blood Flow

1985